Showing results (1941-1950 of 10,442) with videos related to

Sort By:
Pageof 1,045
AIDS (London, England)|June 7, 2013
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patientsEugenia Vispo, José Vicente Fernández-Montero, Pablo Labarga, et al.
AIDS (London, England)|November 2, 2013
Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infectionJosué Pérez-Santiago, Sara Gianella, Marta Massanella, et al.
AIDS (London, England)|November 2, 2013
Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotypeHelen M McIlleron, Michael Schomaker, Yuan Ren, et al.
AIDS (London, England)|November 5, 2013
Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infectionMaria C Puertas, Marta Massanella, Josep M Llibre, et al.
AIDS (London, England)|November 9, 2013
HIV infection of human regulatory T cells downregulates Foxp3 expression by increasing DNMT3b levels and DNA methylation in the FOXP3 geneMarjorie Pion, Didiana Jaramillo-Ruiz, Alberto Martínez, et al.
AIDS (London, England)|October 26, 2013
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in FranceMarie Leoz, Felix Feyertag, Charlotte Charpentier, et al.
AIDS (London, England)|September 28, 2013
Antiretroviral therapy increases thymic output in children with HIVKatrine S Sandgaard, Joanna Lewis, Stuart Adams, et al.
AIDS (London, England)|September 28, 2013
IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patientsSandra Franco, Ester Aparicio, Mariona Parera, et al.
AIDS (London, England)|October 1, 2013
High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV careMatthew R Lamb, Ruby Fayorsey, Harriet Nuwagaba-Biribonwoha, et al.
AIDS (London, England)|October 9, 2013
The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine developmentYu Zhang, Tingting Yuan, Jingjing Li, et al.
Pageof 1,045